This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Mereo Biopharma 1 Limited. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Paul Andrew Ford: Innovator in Respiratory Treatment
Introduction
Paul Andrew Ford is a notable inventor based in Horsham, GB. He has made significant contributions to the field of medicine, particularly in the treatment of chronic obstructive pulmonary disease (COPD). His innovative approach has led to the development of a unique pharmaceutical solution aimed at alleviating acute exacerbations of this debilitating condition.
Latest Patents
Ford holds a patent for the "Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease." This patent specifically covers the use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide or a pharmaceutically acceptable derivative thereof in the manufacture of a medicament for treating acute exacerbations of COPD. The treatment may involve a single dose of the active ingredient administered orally.
Career Highlights
Paul Andrew Ford is associated with Mereo Biopharma 1 Limited, where he continues to work on innovative solutions for respiratory diseases. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Paul Andrew Ford's contributions to the treatment of chronic obstructive pulmonary disease through his innovative patent demonstrate his commitment to improving patient outcomes. His work at Mereo Biopharma 1 Limited highlights the importance of continued research in the field of respiratory medicine.